RSCM
LEGN icon

Rock Springs Capital Management’s Legend Biotech LEGN Stock Holding History

Rock Springs Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$967K Sell
33,500
-7,000
-17% -$189K 0.05% 100
2026
Q1 		$733K Buy
40,500
+6,700
+20% +$128K 0.04% 96
2025
Q4 		$735K Buy
+33,800
New +$968K 0.04% 97
2025
Q2 		– Sell
-512,932
Closed -$17.4M – 97
2025
Q1 		$17.4M Buy
512,932
+800
+0.2% +$28.7K 1% 37
2024
Q4 		$16.7M Buy
512,132
+3,200
+0.6% +$133K 0.63% 49
2024
Q3 		$24.8M Buy
508,932
+3,146
+0.6% +$168K 0.81% 46
2024
Q2 		$22.4M Buy
505,786
+6,300
+1% +$291K 0.67% 48
2024
Q1 		$28M Buy
499,486
+7,042
+1% +$425K 0.71% 50
2023
Q4 		$29.6M Buy
492,444
+34,179
+7% +$2.17M 0.73% 45
2023
Q3 		$30.8M Hold
458,265
– – 0.82% 38
2023
Q2 		$31.6M Hold
458,265
– – 0.75% 45
2023
Q1 		$22.1M Buy
458,265
+7,799
+2% +$381K 0.53% 53
2022
Q4 		$22.5M Hold
450,466
– – 0.54% 53
2022
Q3 		$18.4M Buy
450,466
+94,899
+27% +$4.45M 0.47% 60
2022
Q2 		$19.6M Sell
355,567
-55,617
-14% -$2.35M 0.57% 51
2022
Q1 		$14.9M Buy
411,184
+7,600
+2% +$300K 0.38% 68
2021
Q4 		$18.8M Buy
403,584
+88,366
+28% +$4.48M 0.43% 68
2021
Q3 		$15.9M Buy
315,218
+2,600
+0.8% +$108K 0.34% 81
2021
Q2 		$12.8M Hold
312,618
– – 0.25% 101
2021
Q1 		$9.07M Buy
312,618
+3,200
+1% +$87.3K 0.2% 120
2020
Q4 		$8.71M Buy
309,418
+57,280
+23% +$1.65M 0.18% 118
2020
Q3 		$7.78M Buy
252,138
+46,242
+22% +$1.56M 0.2% 113
2020
Q2 		$8.76M Buy
+205,896
New +$8.04M 0.24% 107

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Rock Springs Capital Management's LEGN Position: Q2 2026 in Review

Rock Springs Capital Management reduced its Legend Biotech (LEGN) stake by 17% in Q2 2026, selling an estimated $189K and leaving 33,500 shares worth $967K. The position accounts for 0.05% of the portfolio, ranked #100.

Rock Springs Capital Management first reported a position in LEGN in Q2 2020 and has held it in 23 quarters since. The position peaked at $31.6M in Q2 2023. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Rock Springs Capital Management held 33,500 shares of Legend Biotech worth $967K as of Q2 2026.
  • Rock Springs Capital Management sold 7,000 Legend Biotech shares in Q2 2026, an estimated $189K.
  • Legend Biotech made up 0.05% of Rock Springs Capital Management's portfolio in Q2 2026, its #100 holding.
  • Rock Springs Capital Management first reported a position in Legend Biotech in Q2 2020 and has held it in 23 quarters since.
  • Rock Springs Capital Management's Legend Biotech position peaked at $31.6M in Q2 2023.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Rock Springs Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.